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Background: Carbapenems are the antibiotics of choice to treat infections caused by Acinetobacter baumannii, and
resistance to this class can be determined by loss of membrane permeability and enzymatic mechanisms. Here, we
analyzed the basis of carbapenem resistance in clinical A. baumannii isolates from different Brazilian regions.
Results: The analyses addressed the carbapenemase activity of OXA-23, CarO expression and alterations in its primary
structure. Susceptibility test revealed that the strains presented the COS (Colistin-Only-Sensitive) profile. PCR and
sequencing showed the presence of the chromosomally-encoded blaOXA-51 in all isolates. The majority of strains (53%)
carried the carbapenemase blaOXA-23 gene associated with ISAba1. The Hodge test indicated that these strains are
carbapenemase producers. PFGE revealed 14 genotypes among strains from Rio de Janeiro and Maranhão. The
influence of carO on imipenem resistance was evaluated considering two aspects: the composition of the primary
amino acid sequence; and the expression level of this porin. Sequencing and in silico analyses showed the occurrence
of CarOa, CarOb and undefined CarO types, and Real Time RT-PCR revealed basal and reduced carO transcription levels
among isolates.
Conclusions: We concluded that, in general, for these Brazilian isolates, the major carbapenem resistance mechanism
was due to OXA-23 carbapenemase activity and that loss of CarO porin plays a minor role in this phenotype. However,
it was possible to associate the carO alleles and their expression with imipenem resistance. Therefore, these findings
underline the complexity in addressing the role of different mechanisms in carbapenem resistance and highlight the
possible influence of CarO type in this phenotype.
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Acinetobacter baumannii has been considered one of
the major nosocomial pathogens worldwide, and it is in-
cluded in the group of ESKAPE bugs, in which some lin-
eages effectively escape the action of antibacterial drugs
[1]. Carbapenems remain the antibiotic of choice to treat
A. baumannii and other Gram-negative infections due
to both a wider spectrum of antibacterial activity and
less frequent side effects. However, their overuse and
misuse have selected for nosocomial isolates presenting* Correspondence: ericafon@ioc.fiocruz.br
1Laboratório de Genética Molecular de Microrganismos, Instituto Oswaldo
Cruz, FIOCRUZ, Rio de Janeiro, Brazil
Full list of author information is available at the end of the article
© 2013 Fonseca et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the orintrinsic and acquired multidrug resistance determinants
[2]. It has been considered that resistance against carba-
penems is, in itself, sufficient to define an A. baumannii
as highly resistant [3]. The molecular basis of carba-
penem resistance in this species has been ascribed to the
recruitment and production of carbapenem-hydrolysing
class D β-lactamases (CHDLs) and, to a lesser extent, of
metallo-β-lactamases (MBLs). In A. baumannii, the CHDLs
can be intrinsic (OXA-51-like) or acquired (OXA-23-like,
OXA-24-like and OXA-58-like) [3]. Although these en-
zymes weakly hydrolyze carbapenems, they can confer high
resistance when blaOXA genes are overexpressed, as a result
of their association with mobile elements, such as ISAba1,
which carries a strong promoter [4]. The blaOXA-23 gene, inl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Fonseca et al. BMC Microbiology 2013, 13:245 Page 2 of 7
http://www.biomedcentral.com/1471-2180/13/245association with ISAba1, is spread in A. baumannii world-
wide, and it is the most prevalent OXA allele in isolates
from Brazil [3,5-7].
In addition to this enzymatic resistance, the loss of
membrane permeability, due to alterations in specific por-
ins, is an intrinsic carbapenem resistance mechanism in
A. baumannii. The 25/29 kDa heat-modifiable carba-
penem-associated outer membrane protein (CarO) is a
porin with a β-barrel topology. This channel allows the se-
lective uptake of amino acids and imipenem (but not mero-
penem) due to its structural conformation and to the
presence of an imipenem binding site [8,9]. This site was
not found in any other OMP, and thus, CarO protein is
considered a preferred uptake channel for this antibiotic.
Based on variable domains of CarO, this channel is classi-
fied in two groups, CarOa and CarOb, with high affinity to
imipenem. Moreover, CarOb was showed to be twice more
specific for imipenem than the CarOa. In this way, carO
gene alterations, as disruption by insertion sequences,
changes in the primary structure - mainly in the imipenem
binding site - or decreased expression, would have a dra-
matic impact on the entry of imipenem in the cell, thus
contributing to resistance to this antibiotic [9]. Concern-
ing the participation of CarO porin in the resistance
phenotype, few descriptive studies have only shown the
presence/absence of the gene and protein, resulting in a
lack of studies showing the association of the carO alleles
and their expression with the resistance phenotype.
Brazil is a continental country and, concerning resist-
ance in A. baumannii, the studies have been concen-
trated in the Southeast region [5,7], which could not be
representative of the A. baumannii diversity as showed
previously [10]. Therefore, the role of CarOa and CarOb
in the differential imipenem uptake, and the current di-
versity of carO alleles available in the GenBank lead us to
investigate these aspects in a set of carbapenem-resistant
clinical A. baumannii strains from two Brazilian states
placed ~3,000 Km apart and with distinct ecological and
social contexts. Moreover, the prevalence and participa-
tion of carbapenemases in this phenotype was also
evaluated.
Results and discussion
All the 28 strains were resistant to, at least, meropenem.
Most of the strains from both Rio de Janeiro and Maranhão
were resistant to ceftazidime, cefepime, ciprofloxacin, tri-
methoprim, amikacin and streptomycin (Table 1). A con-
siderable discrepancy was observed between strains from
Rio de Janeiro and Maranhão concerning the resistance to
aztreonam, gentamicin, piperacillin/tazobactam, ertapenem,
and imipenem (Table 1). Three/thirteen (23%) strains from
Rio de Janeiro were resistant to imipenem contrasting with
13/15 (86.6%) resistant strains from Maranhão. All strains
from this study were susceptible to tigecycline and colistin(MICs ranging from 0.25 to 0.50 μg/mL), and strains resist-
ant to imipenem presented MICs ≥ 32 μg/mL.
All strains harboured the chromosomally-encoded
blaOXA-51 gene, however, the ISAba1 was not associated
to this allele in any strain. In fact, the ISAba1-blaOXA-51
combination is not frequent [5], although a previous
study had found this association in the Southern region
of Brazil [7]. Additionally to blaOXA-51, 13/15 (86.6%)
strains from Maranhão carried also the CHDL blaOXA-23
gene, while only 2/13 (15%) strains from Rio de Janeiro
(AC2-RJ and AC72-RJ) harboured this allele. Spite the
low prevalence of blaOXA-23 in AC-RJ strains (this work)
and in São Paulo [6], it is the most prevailing and
disseminated allele in Brazil. All blaOXA-23 from both
Maranhão and Rio de Janeiro were preceded by ISAba1
as found in previous works from several Brazilian states
[5,7]. Therefore, the high imipenem resistance (MIC, ≥
32 μg/mL) presented in all strains harbouring blaOXA-23
can be due to its overexpression driven by the ISAba1
promoter [4]. All strains from Rio de Janeiro, except by
AC2-RJ and AC72-RJ, carried blaOXA alleles of narrow
resistance spectrum (blaOXA-13, −10 or −66), none of them
associated with ISAba1, spite its presence in AC-RJ
strains (Table 1). The isolates were negative for MBL
genes, blaOXA-58-like and blaOXA-24-like alleles. In sum-
mary, our results revealed that only OXA with carbape-
nemase activity (blaOXA-23) was associated with ISAba1
in the strains analyzed here, and that all of them were
resistant to carbapenems. These results are summarized
in Table 1.
The Hodge test was in agreement with the carbapene-
mase activity and the consequent carbapenem resistance,
where positive results were obtained only for the strains
carrying ISAba1-blaOXA-23, while negative results were
observed for strains harbouring OXA alleles with no or
a weak carbapenemase activity. Thus, these results re-
flect the OXA-23 overexpression driven by the strong
promoter [4,11] found in ISAba1 (Table 1).
A. baumannii has a clonal structure population [12],
however, several unrelated carbapenem-resistant lineages
have been reported in Brazil [13,14]. In the present
work, macrorestriction analyses revealed eight genotypes
in Rio de Janeiro (A-H) and six genotypes in Maranhão
(I-N), totalizing 14 clones, none of them related to the
international clones. In Maranhão, the majority of
strains (8/15) belonged to genotype I, however in Rio de
Janeiro there was no predominant genotype. In this
study, the blaOXA-23 gene was distributed in several ge-
notypes, while in São Paulo this allele occurred in only
one genotype [6]. These findings show the diversity of
clinical A. baumannii circulating in Brazil. One strain of
each genotype was selected as a representant to perform
further analyses of carO transcription and gene sequen-
cing (Table 1).
Table 1 Genetic and phenotypic features of A. baumannii Brazilian strains analyzed in this study













AC2-RJ (1) B 0.41 CarOa blaOXA-23 + + + ATM CAZ CIP MEM IPM EPM
TMP GEN AMK STR
≥ 32
AC1-RJ (1) A 1.33 CarOa blaOXA-13 + - - ATM CAZ FEP CIP MEM TMP STR 1.0
AC3-RJ (3) C 1.21 CarOa blaOXA-66 + - - ATM CAZ FEP CIP MEM TMP
AMK STR
1.0
AC10-RJ (1) F 1.23 CarOa blaOXA-10 + - - ATM CIP MEM TMP GEN
AMK STR
1.0
AC6-RJ (3) D 1.07 Undefined CarO blaOXA-13 + - - ATM CAZ FEP CIP MEM IPM
EPM TZP TMP GEN AMK STR
32
AC9-RJ (1) E 0.10 CarOb blaOXA-10 + - - ATM CIP MEM TMP GEN STR 0.25
AC16-RJ (2) G 0.86 CarOb blaOXA-10 + - - ATM CAZ FEP CIP MEM TZP
TMP AMK STR
1.5
AC72-RJ (1) H 0.94 CarOa blaOXA-23 + + + ATM CAZ CIP MEM IPM EPM
TMP AMK STR
≥ 32
AC60-MA (1) L 0.05 Disrupted by ISAba1 - + - - MEM EPM 0.20
AC62-MA (2) J 0.45 CarOa blaOXA-23 + + + ATM CAZ FEP CIP MEM IPM
EPM TZP TMP AMK STR
≥ 32
AC65-MA (1) M 0.50 CarOb blaOXA-23 + + + ATM CAZ FEP CIP MEM IPM
EPM TZP TMP GEN AMK STR
≥ 32
AC67-MA (8) I 0.65 Undefined
CarO
blaOXA-23 + + + CAZ FEP CIP MEM IPM EPM
TZP TMP GEN AMK STR
≥ 32
AC70-MA (1) N 1.55 CarOa blaOXA-66 + - - ATM CAZ FEP CIP MEM EPM
TZP TMP GEN AMK STR
1.0
AC71-MA (2) K 0.45 Undefined CarO blaOXA-23 + + + CAZ FEP CIP MEM IPM EPM
TZP TMP GEN AMK STR
≥ 32
ATCC 19606 1.00 CarOa 0.25
aall isolates also harboured the blaOXA-51 gene.
bno blaOXA-51 was associated with ISAba1.
ATM aztreonam, CAZ ceftazidime, FEP cefepime, CIP ciprofloxacin, MEM meropenem, IPM imipenem, EPM ertapenem, TZP piperacillin/tazobactam, TMP
trimethoprim, GEN gentamicin, AMK amikacin, STR streptomycin.
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enced in three aspects: i) the occurrence of gene disrup-
tion resulting in the lack of porin formation in the outer
membrane; ii) amino acid changes in both CarOa and
CarOb that could account for an altered porin with low
or no affinity for the antibiotic and/or; iii) decrease ex-
pression of the carO gene that causes a low density of
channels. Therefore, to fully investigate these aspects, it
is necessary to assess the carO nucleotide and deduced
amino acid sequences and its expression. However, there
is a lack of this set of data when the role of carO in imi-
penem resistance is addressed.
Here, in order to raise all these information concern-
ing carO, we analyzed the expression of this gene by
relative quantification, and the nucleotide/predicted
amino acid sequences were determined to type the CarO
(CarOa or CarOb) and to evaluate gene disruption by IS.
The carO sequences from AC-RJ and AC-MA presented
substitutions without the presence of frameshifts and/or
premature stop codons when compared to CarO of A.
baumannii ATCC 19606. Analyses of the carO promoterregion showed that all strains harbour the canonical se-
quence as described previously [15].
The predicted amino acid sequence showed that
CarOa and CarOb were distributed among isolates from
Maranhão and Rio de Janeiro. Moreover, blastX analyses
revealed CarO sequences with amino acid differences
considering both CarOa and CarOb, which was named
here undefined CarO (Table 1 and Figure 1). The un-
defined CarO porins (AC6-RJ, AC-67-MA and AC71-
MA) presented one to five amino acid differences among
each other, with 70% and 74% identity with CarOa and
CarOb, respectively. One of these, from AC6-RJ, is iden-
tical to a CarO previously identified in Argentina [Gen-
Bank: AAV80243] [15]. AC67-MA and AC71-MA
carried two new undefined CarO with 98% and 99%
amino acid identity, respectively, with CarO sequences
identified in strains from Germany, United States, Leban
and China [GenBank: EKL39362, EKL48836, ABG27024,
AFH56947, respectively] (Figure 1). Therefore, taking
into account the observed CarO diversity, and that
the CarO primary structure influence the imipenem
Figure 1 Alignment of A. baumannii CarO amino acid sequences from this study and available in GenBank. The ATCC 19606 [GenBank:
ZP_05828783.1] and A6 [GenBank: ADQ27797.1] CarO sequences were selected as the representants of the CarOa and CarOb groups, respectively.
Ab244 [GenBank: AAV80243; Argentina], Acb-1 [GenBank: ABG27024; Leban], ZJM007 [GenBank: AFH56947; China], OIFC074 [GenBank: EKL39362;
Germany] and Naval-83 [GenBank: EKL48836; United States] were representants of different undefined CarO isoforms. The numbers correspond to
amino acid positions. The gray box labels the CarOb group.
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impact of other isoforms on this phenotype has to be
investigated.
Considering the imipenem-susceptible strains, relative
quantification assay revealed that AC1-RJ (CarOa), AC3-
RJ (CarOa), AC10-RJ (CarOa), AC16-RJ (CarOb), and
AC70-MA (CarOa) had a basal transcription level of
carO as ATCC 19606 (Table 1). For this group of strains,
the carO transcript amount and the type of CarO were
in agreement with the imipenem susceptibility pheno-
type (Table 1). Moreover, these strains did not produce
carbapenemases. However, the carO expression did not
correlate with this phenotype in the imipenem-susceptible
AC60-MA and AC9-RJ strains. In AC60-MA, which is
highly susceptible to imipenem (MIC, 0.20 μg/mL), the
carO gene was disrupted by the ISAba1 (Table 1). There-
fore, the porin loss in this strain was not evoking resist-
ance, indicating the participation of other mechanisms in
the imipenem uptake. Similarly, AC9-RJ, susceptible to
imipenem (MIC, 0.25 μg/mL), presented a 10-fold de-
crease in carO expression. It can be suggested that, appar-
ently, this 10-fold expression reduction was not enough
to cause the total loss of porin formation. Interestingly,
AC9-RJ has a porin from the CarOb group, which is more
specific towards imipenem than CarOa [9]. Thus, even in
lower amounts of the porin, the imipenem uptake can be
occurring due to CarO structural conformation in this
strain, explaining its susceptibility to imipenem.
Considering the imipenem-resistant strains, AC2-RJ
(CarOa), AC62-MA (CarOa), AC65-MA (CarOb), AC67-
MA (undefined CarO) and AC71-MA (undefined CarO)
had low carO transcript amounts (Table 1). The exception
was AC72-RJ, which presented basal carO transcription.
All of them produce the CHDL OXA-23, and therefore,
it was not possible to establish the contribution of CarO
in this resistance phenotype (Table 1). Conversely, the
imipenem-resistant AC6-RJ strain (MIC, 32 μg/mL), pre-
sented basal carO transcription level (1.07-fold), and no
carbapenemase production was detected (Table 1). As
showed above, the AC6-RJ harbours an undefined CarO
type, presenting 70% and 74% amino acid identity with
CarOa and CarOb, respectively. Therefore, these CarO
could have an altered imipinem binding site, influencing
the antibiotic affinity, resulting in the observed resistance.
In fact, this undefined CarO from AC6-RJ was identical to
that from Ab244 strain from Argentina, which has been
shown to play an essential role in the selective uptake of
L-ornithine, but not of imipenem [8,9].
Therefore, to correlate CarO with imipenem resistance,
not only the expression has to be considered, but also the
CarO primary sequence. The results obtained for AC6-RJ
and AC9-RJ provide evidences of a possible correlation be-
tween CarO isoforms and imipenem resistance/susceptibil-
ity phenotype (Table 1). Moreover, PROVEAN analysesrevealed that the amino acid substitutions (approximately
67 residues) found in the different undefined CarO identi-
fied in this study had a neutral impact in protein function.
These results indicate that even with this high proportion
of substitutions they are not interfering with CarO function
and formation.
The particular role of some CarO (CarOa and CarOb)
in the imipenem affinity had been experimentally deter-
mined by Catel-Ferreira and colleagues [9]. Vashist et al.
[16] indirectly showed a correlation between expression,
the CarO isoform and imipenem resistance based on
proteomic approaches. Here, we directly determined the
CarO isoforms by assessing the substitutions in the
amino acid primary sequence and the transcription level
of CarO. Also, Vashist and colleagues showed that al-
tered CarO isoforms were upregulated while the native
CarO (CarOa and CarOb) were downregulated in
carbapenem-resistant A. baumannii. These results ob-
tained at the post-translational level contrast with ours
since no correlation between the CarO (native or un-
defined) and the transcription level (up and downregula-
tion) was observed in this study (Table 1). This reflects
that post-transcriptional events may be occurring during
porin formation in the membrane, since in that work the
authors analyzed the protein. Therefore, our study is the
first to infer the role of CarO on imipenem resistance
considering its expression and allelic diversity.
Conclusions
Studies in distinct Brazilian geographic regions have
already shown the prevalence of OXA-23 among the
several CHDLs in imipenem resistant A. baumannii
strains [5,7]. However, there is a lack of data concerning
the influence of membrane permeability loss in this
phenotype. We concluded that, spite of the carbapene-
mase production being the major carbapenem resistance
mechanism in A. baumannii analyzed here, the amino
acid composition of CarO porins can affects more dras-
tically the imipenem resistance than the transcription
level itself. Therefore, these findings highlight the pos-
sible role of CarO isoforms in this phenotype.
Methods
Bacterial strains and detection of carbapenem-resistance
genes
The study included 28 clinical carbapenem-resistant
A. baumannii belonging to the Bacterial Culture Collection
of Environment and Health (CBAS) from the Oswaldo
Cruz Institute (FIOCRUZ). The isolates were recovered
from Maranhão in 2006 (n = 15) and Rio de Janeiro in 2008
(n = 13), and presented a COS phenotype, with the ex-
ception of AC60-MA strain. PCR and sequencing reac-
tions were performed targeting the MBLs genes blaIMP
and blaVIM alleles, blaSPM-1, and blaNDM-1; and the
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blaOXA-143 and other OXA alleles (Table 2), alone and
downstream ISAba1. Also, the entire carO gene and its
promoter region were evaluated. Primer list is detailed in
Table 2.
Antimicrobial susceptibility testing
The resistance phenotype was obtained by the disc-
diffusion method [17] for the following antibiotics: aztre-
onam, cefepime, ceftazidime, piperacillin-tazobactam,
ciprofloxacin, trimethoprim, imipenem, meropenem,
ertapenem, gentamicin, amikacin, streptomycin, colistinTable 2 Primers used in this study
Primers for PCR and sequencing
Primer
name
Primer sequence (5′→ 3′) Target gene
IMP F GCATTGCTACCGCAGCAGAG blaIMP alleles
IMP R GGTTTAAYAAAACAACCAC
VIM F TCGGAGAGGTCCGACTTTACC blaVIM alleles
VIM R CCATTCAGCCAGATCGG
SPM-1 F ACGTTTTCGTCGTCACAG blaSPM-1 gene
SPM-1 R GTCCAGGTATAACAATTTTCG
NDM-1 F AATGGAATTGCCCAATATTATGC blaNDM-1 gene
NDM-1 R TCAGCGCAGCTTGTCGGC





OXA SET A R TTAAATGATTCCAAGATTTTC
OXA SET B F ACAGAARTATTTAAGTGGG blaOXA-51-like and
blaOXA-58-like allelesOXA SET B
Ra
GGTCTACAKCCMWTCCCCA
OXA SET C F ATGAAAACATTTGCCGCATA blaOXA-10-like alleles
OXA SET C R CGTTGTCTATATCCATGTTA
ISABA1 F GTGCTTTGCGCTCATCATGC ISAba1
ISABA1 R CATGTAAACCAATGCTCACC
ISABA1 F2b AGTTGCACTTGGTCGAATGA Detection of ISAba1
upstream blaOXA-51
and blaOXA-23
CARO F GCTCACCTGATGCTGACATT carO gene and its
promoter
CARO R TTGCTTCTTCAACAGCTTGG
CARO F SQ GCGGCTTACCTTGATAACG carO gene sequencing
CARO R SQ TTACGAGCTTCCGCATTTAC
Primers for relative quantification
TR CARO F AGCTTTACTTGCTGCTGGTG A. baumannii carO
transcription
TR CARO R CGAGCGCCTACTGGAATTA
TR CPN60 F TTGACCGTGGTTATATCTCTCC A. baumannii cpn60
transcription
TR CPN60 R CGGATTTTCAAGTTCAGCAG
a Used in combination to amplify the blaOXA-143 allele.
bused in combination with OXA SET B R and with OXA-23 R primers.and tigecycline. The MIC was determined by E-Test
method (Biomerieux) for imipenem and colistin.Evaluation of carbapenemase production
The carbapenem-resistant isolates were submitted to the
modified Hodge test [18] in order to detect the carbape-
nemase production. In summary, the assay was carried
out on Müeller-Hinton agar plates using ertapenem,
meropenem and imipenem disks. The blaSPM-1 MBL-
producing Pseudomonas aeruginosa (PS600) from CBAS
and the Escherichia coli strain ATCC 25922 were used
as positive and negative controls, respectively.PFGE genotyping
PFGE analyses were performed using ApaI (New England
Biolabs) restriction enzyme in order to determine the gen-
etic relationship among A. baumannii isolates. The gen-
etic relatedness was attributed when the macrorestriction
DNA patterns differed by fewer than three bands [19].Relative quantification of CarO porin
The carO transcription was evaluated by real time RT-
PCR using Power-SYBR Green PCR Master Mix (Applied
Biosystems). The single-copy housekeeping cpn60 gene
from A. baumannii, coding for a 60-kDa chaperonin, was
used as endogenous gene for normalization. The relative
quantification (RQ) results were presented as ratios of
normalized target gene transcription between the A. bau-
mannii clinical isolates and the Type Strain ATCC 19606
(calibrator), which were obtained according to the follow-
ing equation: RQ = 2-ΔΔCT, where CT is the value corre-
sponding to the crossing point of the amplification curve
with the threshold; ΔCT = target CT or calibrator CT –
endogenous CT; and ΔΔCT = target ΔCT – calibrator
ΔCT. carO differential transcription of clinical strains rela-
tive to that of ATCC 19606 was considered significant
when the ratios obtained between RQ values (RQ value of
calibrator/RQ value of clinical strains) were ≥2.0, taking
into account the standard deviation intervals.CarO amino acid sequence alignment and in silico
analyses
The deduced amino acid sequences from the carO ob-
tained in this study and from the CarOa (ATCC 19606
strain), CarOb (A6 strain) and several undefined CarO
sequences available in GenBank were aligned using Clus-
talW. In order to verify whether the amino acid changes
observed in the undefined CarO isoforms relative to the
canonical CarOa are deleterious, in silico analyses was per-
formed with the software PROVEAN (http://provean.jcvi.
org/), which predicts if an amino acid substitution or indel
has any impact on the biological function of a protein.
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